Navigation Links
Thoratec Announces Presentations At Investor Conferences For December 2013
Date:11/27/2013

PLEASANTON, Calif., Nov. 27, 2013 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in two upcoming investor conferences.

On Wednesday, December 4, the company will participate in the Piper Jaffray 25th Annual Health Care Conference. Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on the company, beginning at 12:00 p.m., Eastern Standard Time (9:00 a.m., Pacific Standard Time). A webcast of the presentation will be available at http://www.media-server.com/m/p/2k89k7xb, or on the company's website at http://www.thoratec.com.

On Tuesday, December 10, Thoratec will participate in the Oppenheimer 24th Annual Healthcare Conference. The presentation by Taylor C. Harris, Vice President and Chief Financial Officer, will begin at 2:10 p.m., Eastern Standard Time (11:10 a.m., Pacific Standard Time).  A webcast of the presentation will be available at http://www.veracast.com/webcasts/opco/healthcare2013/08112471883.cfm, or on the company's website at http://www.thoratec.com.

Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's products include the HeartMate® LVAS (Left Ventricular Assist System) and Thoratec® VAD (Ventricular Assist Device) with more than 20,000 devices implanted in patients suffering from heart failure. Thoratec also manufactures and distributes the CentriMag® and PediMag®/PediVAS® product lines. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's website at http://www.thoratec.com.

Thoratec, the Thoratec logo, HeartMate and HeartMate II are registered trademarks of Thoratec Corporation and IVAD is a trademark of Thoratec Corporation. CentriMag and PediMag are registered trademarks of Thoratec LLC, and PediVAS is a registered trademark of Thoratec Switzerland GmbH.


'/>"/>
SOURCE Thoratec Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Thoratec Announces Presentations At Investor Conferences For November 2013
2. Thoratec Presentation At Morgan Stanley 2013 Health Care Conference To Be Webcast
3. Thoratec Presentation At Bank of America Merrill Lynch 2013 Health Care Conference To Be Webcast
4. Thoratec Schedules First Quarter Conference Call, Webcast
5. Thoratec Presentation At Barclays Global Healthcare Conference To Be Webcast
6. Thoratec Presentation at Leerink Swann Global Healthcare Conference to Be Webcast
7. Thoratec Schedules Fourth Quarter Conference Call, Webcast
8. Thoratec Presentation At Oppenheimer 23rd Annual Healthcare Conference To Be Webcast
9. Thoratec Presentation At Piper Jaffray 24th Annual Healthcare Conference To Be Webcast
10. Thoratec Presentation At Credit Suisse 2012 Healthcare Conference To Be Webcast
11. Thoratec Reports Third Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... , July 11, 2017  Bayer has awarded grants ... countries as part of its prestigious Bayer Hemophilia Awards Program ... of Philadelphia and Uniformed Services University ... are among the winners. Grant recipients were announced last night ... Hemostasis (ISTH) 2017 Congress, Berlin, Germany . ...
(Date:7/11/2017)... 2017  Sysmex America, Inc., a leading provider ... as well as middleware information systems technology, today ... quality assurance easier and more risk free than ... for the innovation that it delivers to the ... assurance processes to a new level with automated, ...
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... has agreed to schedule an End-of-Phase II meeting with ... its oral insulin capsule ORMD-0801 in the treatment of ... and secondary endpoints by indicating a statistically significant lowering ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... The most ... patients improved quality of life five years after injury, according to research presented ... in Toronto, Ontario, Canada. The study followed patients for five years following surgery. ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) ... progresses rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a ... relapse. With such a challenging diagnosis that requires immediate action, patients and ...
(Date:7/20/2017)... ... July 20, 2017 , ... Remote Medical Technologies (RMT) ... comes included with each system installation. RMT’s iMedHD2™ Telepathology and ... real-time collaboration and immediate decision-making requirements. While never sharing IP addresses, RMT ...
(Date:7/20/2017)... ... July 20, 2017 , ... Girl Up Campaign ... and Senate legislation in support of providing girls access to education in refugee ... 2408, the “Protecting Girls’ Access to Education in Vulnerable Settings Act.” Yesterday, companion ...
(Date:7/20/2017)... ... July 20, 2017 , ... There’s a lot of confusing ... bulging discs are the same thing. But it’s crucial to understand both the differences ... treatment, according to Kaixuan Liu, MD, PhD, founder and president of Atlantic Spine ...
Breaking Medicine News(10 mins):